After two congressional oversight hearings (at which MPP recently testified, see posts below) concerning the environmental release of dental mercury, a US House Government Oversight subcommittee is calling on the Food and Drug Administration to reform its rulemaking on dental mercury, as required by the National Environmental Policy Act. In a July 28, 2008 letter to FDA Commissioner Andrew von Eschenbach, Domestic Policy Subcommittee Chairman Dennis Kucinich reminded FDA of its statutory duty under NEPA to prepare an environmental impact statement or conduct an environmental assessment as part of the rulemaking process in reclassifying dental mercury, classifying encapsulated amalgam alloy and dental mercury or issuing special controls for amalgam alloy.